
All News


Pharmaceutical Executive
In China’s new reform-driven and fast-moving environment for healthcare innovation, intense market pressures and fierce competition will ultimately push all stakeholders to evolve their strategies-or face extinction.

Pharmaceutical Executive
The industry faces a problem of medical education and communication in regards to vaccinations.

Pharmaceutical Executive
A look at drug pricing and patents and the role for patents and how they are under attack.

Pharmaceutical Executive
With so many different rationales for drug pricing and “value” continuing to feed the debate, the market access function in healthcare must clearly tackle these issues-but at what cost to the patient?

FDA has an official new leader, following a Senate vote to confirm Stephen Hahn as the agency’s next commissioner.



Pharmaceutical Executive
With an increase in digital technology being utilized as a strategic differentiator and business enabler in pharma, where is talent coming from?

Pharmaceutical Executive
A new assessment shows year-over-year improvements on meeting DSCSA serialization requirements, which indicate the industry is making steady progress.

Pharmaceutical Executive
Click the title above to open the Pharmaceutical Executive December 2019 issue in an interactive PDF format.

Pharmaceutical Executive
More than two years since the devastation inflicted by Hurricane Maria, Puerto Rico’s supply of medical products has remained largely uninterrupted, debunking common misconceptions at the time and maintaining the island’s standing as one of the most attractive life sciences manufacturing hubs.


Pharmaceutical Executive
A look at the systemic problems resulting from the overlap of MDRP and 340B.

Pharmaceutical Executive
Takeaways from the Healthcare Businesswomen’s Association's 2019 Annual Conference.



Pharmaceutical Executive


Pharmaceutical Executive


Pharmaceutical Executive
A look at how to develop a generic drug and the resources FDA supplies to Abbreviated New Drug Application applications.

A review of the current use of real-world data and evidence in HTA and payer appraisals, its potential role in lifecycle management, and how the early dialogue provided by Integrated Scientific Advice engagement can be used as a key tool in the planning and generation of RWE.

Pharmaceutical Executive
Click the title above to open the Pharmaceutical Executive November 2019 issue in an interactive PDF format.

Pharmaceutical Executive
Click the title above to open Pharmaceutical Executive's 16th Annual Pipeline Report in an interactive PDF format.

Pharmaceutical Executive
Boasting a long and proud tradition in the life sciences, consistently ranked among the world’s most pioneering countries, Sweden’s biggest task will be to maintain such standards in an era where medical science is becoming ever more sophisticated and integrated with other disciplines.

reviews the two most salient changes in Academy of Managed Care Pharmacy's new Format for Formulary Submissions


Pharmaceutical Executive